75000 - Document - Cover Page
link:presentationLink
link:calculationLink
link:definitionLink
75010 - Statement - Unaudited Interim Condensed Statements of Consolidated Financial Position
link:presentationLink
link:calculationLink
link:definitionLink
75020 - Statement - Unaudited Interim Condensed Consolidated Statements of Operations
link:presentationLink
link:calculationLink
link:definitionLink
75030 - Statement - Unaudited Interim Condensed Statements of Consolidated Comprehensive Income (Loss)
link:presentationLink
link:calculationLink
link:definitionLink
75040 - Statement - Unaudited Interim Condensed Statements of Consolidated Comprehensive Income (Loss) 2
link:presentationLink
link:calculationLink
link:definitionLink
75050 - Statement - Unaudited Interim Condensed Statements of Consolidated Cash Flows
link:presentationLink
link:calculationLink
link:definitionLink
75060 - Statement - Unaudited Condensed Statements of Changes in Consolidated Shareholders' Equity
link:presentationLink
link:calculationLink
link:definitionLink
75070 - Statement - Unaudited Condensed Statements of Changes in Consolidated Shareholders' Equity (Parenthetical)
link:presentationLink
link:calculationLink
link:definitionLink
995455 - Disclosure - The Company
link:presentationLink
link:calculationLink
link:definitionLink
995465 - Disclosure - Accounting principles
link:presentationLink
link:calculationLink
link:definitionLink
995475 - Disclosure - Scope of consolidation and non-consolidated entities
link:presentationLink
link:calculationLink
link:definitionLink
995485 - Disclosure - Information concerning the Group's Consolidated Operations
link:presentationLink
link:calculationLink
link:definitionLink
995495 - Disclosure - Impairment tests
link:presentationLink
link:calculationLink
link:definitionLink
995505 - Disclosure - Right-of-use assets
link:presentationLink
link:calculationLink
link:definitionLink
995515 - Disclosure - Property, plant and equipment
link:presentationLink
link:calculationLink
link:definitionLink
995525 - Disclosure - Non-current financial assets and other non-current assets
link:presentationLink
link:calculationLink
link:definitionLink
995535 - Disclosure - Trade Receivables and Other Current Assets
link:presentationLink
link:calculationLink
link:definitionLink
995545 - Disclosure - Financial assets and liabilities
link:presentationLink
link:calculationLink
link:definitionLink
995555 - Disclosure - Current financial assets and Cash and cash equivalents
link:presentationLink
link:calculationLink
link:definitionLink
995565 - Disclosure - Financial liabilities and lease debts
link:presentationLink
link:calculationLink
link:definitionLink
995575 - Disclosure - Other current liabilities
link:presentationLink
link:calculationLink
link:definitionLink
995585 - Disclosure - Deferred income and contract liabilities
link:presentationLink
link:calculationLink
link:definitionLink
995595 - Disclosure - Share capital and premium related to the share capitals
link:presentationLink
link:calculationLink
link:definitionLink
995605 - Disclosure - Non-cash stock-based compensation
link:presentationLink
link:calculationLink
link:definitionLink
995615 - Disclosure - Earnings per share
link:presentationLink
link:calculationLink
link:definitionLink
995625 - Disclosure - Provisions
link:presentationLink
link:calculationLink
link:definitionLink
995635 - Disclosure - Off-balance sheet commitments
link:presentationLink
link:calculationLink
link:definitionLink
995645 - Disclosure - Related parties and other major shareholders
link:presentationLink
link:calculationLink
link:definitionLink
995655 - Disclosure - Subsequent events
link:presentationLink
link:calculationLink
link:definitionLink
995665 - Disclosure - Accounting principles (Policies)
link:presentationLink
link:calculationLink
link:definitionLink
995675 - Disclosure - Accounting Principles (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995685 - Disclosure - Information concerning the Group's Consolidated Operations (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995695 - Disclosure - Right-of-use assets (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995705 - Disclosure - Property, plant and equipment (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995715 - Disclosure - Non-current financial assets and other non-current assets (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995725 - Disclosure - Trade receivables and other current assets (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995735 - Disclosure - Financial assets and liabilities (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995745 - Disclosure - Current financial assets and Cash and cash equivalents (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995755 - Disclosure - Financial liabilities and lease debts (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995765 - Disclosure - Other current liabilities (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995775 - Disclosure - Deferred Income and contract liabilities (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995785 - Disclosure - Share capital and premium related to the share capitals (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995795 - Disclosure - Non-cash stock-based compensation (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995805 - Disclosure - Earnings per share (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995815 - Disclosure - Provisions (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995825 - Disclosure - Off-balance sheet commitments (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995835 - Disclosure - Related parties and other major shareholders (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995845 - Disclosure - Accounting Principles - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995855 - Disclosure - Scope of Consolidation and Non-Consolidated Entities - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995865 - Disclosure - Information Concerning the Group's Consolidated Operations - Revenues by Nature (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995875 - Disclosure - Information Concerning the Group's Consolidated Operations - Revenues by Country of Origin and Other Income (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995885 - Disclosure - Information Concerning the Group's Consolidated Operations - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995895 - Disclosure - Information Concerning the Group's Consolidated Operations - Details of Operating Expenses by Nature (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995905 - Disclosure - Information Concerning the Group's Consolidated Operations - Details of Financial Income and Expenses (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995915 - Disclosure - Information Concerning the Group's Consolidated Operations - Summary of Income Tax Expenses (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995925 - Disclosure - Impairment Tests - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995935 - Disclosure - Right-of-use Assets - Details Information About Breakdown Of Right Of Use Assets (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995945 - Disclosure - Property, Plant and Equipment - Disclosure of Property, Plant and Equipment (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995955 - Disclosure - Non-current Financial Assets and Other Non-current Assets - Summary of Non-current Financial Assets and Other Non-current Assets (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995965 - Disclosure - Non-current Financial Assets and Other Non-current Assets - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995975 - Disclosure - Trade Receivables and Other Current Assets - Disclosure of Trade Receivables (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995985 - Disclosure - Trade Receivables and Other Current Assets - Disclosure of Subsidies Receivables (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995995 - Disclosure - Trade Receivables and Other Current Assets - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996005 - Disclosure - Trade Receivables and Other Current Assets - Disclosure of Other Current Assets (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996015 - Disclosure - Financial Assets and Liabilities - Summary of Financial Assets and Liabilities (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996025 - Disclosure - Current Financial Assets and Cash and Cash Equivalents - Summary of Current Financial Assets and Cash and Cash Equivalents (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996035 - Disclosure - Current Financial Assets and Cash and Cash Equivalents - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996045 - Disclosure - Current Financial Assets and Cash and Cash Equivalents - Summary of Cash and Cash Equivalents (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996055 - Disclosure - Financial Liabilities and Lease Debts - Schedule of Financial Liabilities and Lease Debts (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996065 - Disclosure - Financial Liabilities and Lease Debts - Schedule of reconciliation of movements of liabilities to cash flows arising from financing liabilities (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996075 - Disclosure - Financial Liabilities and Lease Debts - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996085 - Disclosure - Financial Liabilities and Lease Debts - Summary of Assumptions and Results of the Warrant Valuation (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996095 - Disclosure - Financial Liabilities and Lease Debts - Disclosure of Sensitivity on the Expected Volatility (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996105 - Disclosure - Financial Liabilities and Lease Debts - Schedule Representing Remaining Contractual Maturities of Financial Liabilities (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996115 - Disclosure - Other Current Liabilities - Summary of Other Current Liabilities (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996125 - Disclosure - Deferred Income and Contract Liabilities - Summary of Deferred income and Contract Liabilities (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996135 - Disclosure - Deferred Income and Contract Liabilities - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996145 - Disclosure - Share Capital and Premium Related to the Share Capitals - Schedule of Share Capital Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996155 - Disclosure - Share Capital and Premium Related to the Share Capitals - Schedule of Share Capital Information (Parenthetical) (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996165 - Disclosure - Non-cash stock-based compensation - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996175 - Disclosure - Non-cash stock-based compensation - Summary of assumptions Vesting Details (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996185 - Disclosure - Non-cash stock-based compensation - Summary of Information on Stock Option Activity (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996195 - Disclosure - Non-cash stock-based compensation - Summary of Information on Warrants Activity (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996205 - Disclosure - Non-cash stock-based compensation - Summary of Number of Shares Outstanding and Weighted Average Grant Date Fair Value (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996215 - Disclosure - Earnings Per Share - Details of Earnings Per Share (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996225 - Disclosure - Provisions - Summary of Provisions (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996235 - Disclosure - Provisions - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996245 - Disclosure - Off-balance Sheet Commitments - Schedule of Off-balance Sheet Commitments (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996255 - Disclosure - Off-Balance Sheet Commitments - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996265 - Disclosure - Related parties and other major shareholders - Schedule of Outstanding Balances with Related Parties (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996275 - Disclosure - Related parties and other major shareholders - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996285 - Disclosure - Subsequent events - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
Disclosure of financial assets [table]
Financial liabilities at amortised cost
Accounting category amortized cost
Financial liabilities at amortised cost
Current prepaid expenses
Prepaid expenses and other prepayments
Schedule of outstanding balances with related parties explanatory.
Schedule of outstanding balances with related parties explanatory [Table Text Block]
Schedule of outstanding balances with related parties
Sales of non-current financial assets, classified as investing activities.
Sales of Non-Current Financial Assets, Classified as Investing Activities
Sales of non-current financial assets
Proceeds from the sales of non-current financial assets
Reserve of exchange differences on translation
Currency translation adjustment
Cash repayments of advances and loans from related parties
Loan principal payment
Land and buildings [member]
Land and Buildings [Member]
Astra Zeneca Ireland [Member]
Astra Zeneca Ireland [Member]
Research and development expenses.
Research and development expenses [member]
Research and Development Expenses [Member]
Top of range [member]
Top of Range [member]
Interest expense
Increase (decrease) through effect of changes in foreign exchange rates, liabilities arising from financing activities
Currency translation adjustment financial liabilities and lease debts
Other current assets.
Other Current Assets [abstract]
Expected dividends warrants.
Expected Dividends Warrants
Expected dividends
Warrants valuation method.
Warrants Valuation Method
Valuation method
Increase (decrease) through share-based payment transactions, equity
Non-cash stock-based compensation expense
Classes of property, plant and equipment [axis]
Classes of property, plant and equipment [axis]
Income tax receivable current.
Income Tax Receivable Current
Income tax receivable
Payments of lease liabilities, classified as financing activities
Payments on lease debts
Payments of lease liabilities
Increase decrease in other income.
Increase Decrease In Other Income
Increase in other income
Number of exercisable share options forfeited in share based payment arrangement.
Number Of Exercisable Share Options Forfeited In Share Based Payment Arrangement
Option exercisable, forfeited or expired
Non-current lease liabilities
Non-current lease debts
Lease debts
Financial Institution [Domain]
Initial investment agreement.
Initial Investment Agreement [Member]
Agreement one.
Agreement One [Axis]
Classes of financial assets [axis]
S A free shares.
S A Free Shares [member]
S A free shares [member]
Document Fiscal Period Focus
Document Fiscal Period Focus
Derivatives by name.
Derivatives By Name [Domain]
Vesting period, share-based payment arrangements.
Vesting Period, Share-based Payment Arrangements
Vesting period, years
Purchase of other long-term assets, classified as investing activities
Acquisition of non-current financial assets
Purchase of other long-term assets
Grant And Refundable Advance Agreement
Grant And Refundable Advance Agreement [Member]
Grant and refundable advance agreement [Member]
Grant and Refundable Advance Agreement [Member]
This table concepts are used to disclose the amount of expenses aggregated according to their nature (for example, depreciation, purchases of materials, transport costs, employee benefits and advertising costs), and not reallocated among functions within the entity.
Expense By Nature [Table]
Expense By Nature [Table]
Cash flows from (used in) financing activities
Net cash flows from (used in) financing activities
Net cash used in financing activities
Contractual capital commitments
Total commitments
Non current provisions used during the period.
Non Current Provisions Used During the Period
Non current provisions Amounts used during period
Contractual commitments.
Contractual commitments
Total commitments
Other current financial assets
Other current financial assets (deposits)
Schedule disclosing information related to details of non-current financial assets and other non-current assets explanatory.
Schedule Disclosing Information Related to Details of Non-Current Financial Assets and Other Non-Current Assets Explanatory [Text Block]
Summary of Non-current Financial Assets and Other Non-current Assets
Joint collaboration and research agreement.
Joint collaboration and research agreement [member]
Joint Collaboration and Research Agreement [Member]
Borrowing extended period
Borrowing extended period.
Borrowing extended period
Effect of exchange rate changes on cash and cash equivalents
Effects of exchange rate changes on cash and cash equivalents
Disclosure of reconciliation of liabilities arising from financing activities [line items]
Agreement
Agreement [Domain]
Number of share options exercisable change in conversion ratiosin sharebased payment arrangement.
Number Of Share Options Exercisable Change In Conversion Ratios In Sharebased Payment Arrangement
Option exercisable, change in coversion ratios
Classes of commitments.
Classes of commitments [domain]
Disclosure of quantitative information about leases for lessee [abstract]
Finance costs
Financial expenses
Total Financial expenses
Percentage of changes in income tax expense.
Percentage Of Changes In Income Tax Expense
Percentage change
Accruals and deferred income including contract liabilities.
Accruals and deferred income including contract liabilities [Table]
The expected term of the options (in years) at grant date used to calculate the fair value of share options granted.
Description Of Expected Term Of Share Options Granted
Expected term (in years)
Current financial liabilities.
Current financial liabilities [member]
Current Financial Liabilities [member]
Not later than one year [member]
Less than One Year [member]
Describes whether the instruments granted in share-based payment arrangements vest in instalments over a specified period (aka graded vesting) or vest all at once on a specified date (aka cliff vesting).
Vesting Period For Share Based Payment Arrangements
Vesting period
Operating (expenses) and other operating income.
Operating (expenses) and other operating income
Total operating expenses and other operating income
The amount of provisions for employee litigation and serverance.
Provisions for employee litigation and serverance
Employee litigation and severance, Ending balance
Employee litigation and severance, Beginning balance
Interest income on cash, cash equivalents and financial assets.
Interest income on cash, cash equivalents and financial assets
Income from cash, cash equivalents and financial assets
Other provision for charges used during the period.
Other Provision for Charges Used During The Period
Other provision for charges, Amounts used during the period
Segments [domain]
Classes of intangible assets and goodwill [domain]
Major Shareholders [Domain]
Major shareholders.
Increase (Decrease) in Non-current Research Tax Credit Receivables Due to Foreign Exchange Impact
Increase (decrease) in non-current research tax credit receivables due to the foreign exchange impact
Increase (decrease) in non-current research tax credit receivables due to the foreign exchange impact
Provision for tax litigation during the period.
Provision For Tax Litigation During The Period
Provision for tax litigation, During the period
Financial liabilities
Financial liabilities at end of period
Financial liabilities at beginning of period
Book value on the statement of financial position
Total financial liabilities
Book value on the statement of financial position
The weighted-average exercise price of stock options for which the conversion ratios were modified during the period.
Weighted Average Exercise Price Of Additional Share Due To Change In Conversion Ratios Share Based Payment Arrangement
Weighted- average exercise price per share, Additional shares due to change in conversion ratios
Fair value of expected volatility amount.
Fair Value Of Expected Volatility Amount
Expected volatility
Fair value in $ thousands
Amount to be repaid.
Amount to be repaid
Conditional Advances.
Conditional Advances [Member]
Disclosure of detailed information about fair value share price explanatory.
Disclosure Of Detailed Information About Fair Value Share Price [Text Block]
Fair value of Initial Investment Agreement at Initial Recognition Date Determined on Basis of Share Price
Tranche C Warrants [Member].
Tranche C Warrants [Member]
Cash and cash equivalents
Cash and cash equivalents at the end of the period
Cash and cash equivalents
Total cash and cash equivalents
Cash and cash equivalents at the beginning of the year
Profit (loss) from operating activities
Operating income (loss)
Operating income (loss) before tax
Operating loss
State guaranted loan.
State Guaranted Loan [Member]
Non-Current Portion of State-Guaranteed Loan
Non-Current Portion of State-Guaranteed Loan [Member]
Non-Current Portion of State-Guaranteed Loan
Accruals and deferred income including contract liabilities [abstract]
Assets [abstract]
ASSETS
The entire disclosure of trade receivables and other current assets Explanatory
Trade receivables and other current assets Explanatory
Trade receivables and other current assets
Geographical [Domain]
Gains on change in fair value of derivatives
Gain on change in fair value measurement recognized
Gain on fair value measurement
Gain in fair value recognized in profit and loss
Disclosure of transactions between related parties [abstract]
Comprehensive income
Total Comprehensive income (loss)
Disclosure Of Number And Weighted Average Exercise Prices Of Share Options and Awards [Table]
Disclosure Of Number And Weighted Average Exercise Prices Of Share Options and Awards [Table]
Disclosure Of Number And Weighted Average Exercise Prices Of Share Options and Awards [Table]
Income taxes paid (refund), classified as operating activities
Income taxes refund (paid)
Income tax received (paid)
Proceeds from sale of preferred shares.
Proceeds From Sale Of Preferred Shares
Proceeds from sale of preferred shares
Research tax credit financings.
Research Tax Credit Financings [Member]
Research Tax Credit Financings [Member]
Other current liabilities1.
Other Current Liabilities 1- [Member]
Other Current Liabilities [member]
Financial liabilities at fair value through profit or loss, category [member]
Financial Liabilities at Fair Value through Profit or Loss, Category [Member]
Disclosure of detailed information of reconciliation of changes in right of use assets explanatory
Disclosure of detailed information of reconciliation of changes in right of use assets explanatory.
Disclosure of Detailed Information About Breakdown of Right-of-Use Assets Explanatory
Executive Officers [Member]
Pension.
Pension [member]
Pension [member]
Deferred revenues.
Deferred revenues
Deferred revenues and contract liabilities
Deferred revenue
Adjustment for decrease (increase) in trade receivables and other current assets.
Adjustment for Decrease (Increase) in Trade Receivables and Other Current Assets
Decrease (increase) in trade receivables and other current assets
Number of share options exercisable granted in share based payment arrangements.
Number Of Share Options Exercisable Granted In Share Based Payment Arrangements
Option exercisable, granted
Consolidated operations [table].
Consolidated operations [table]
Consolidated operations [table]
Fair values per options.
Fair values per options
Fair value per options
Carrying amount [member]
Carrying amount [member]
Provisions for employee litigation and severance other comprehensive income.
Provisions For Employee Litigation And Severance Other Comprehensive Income
Employee litigation and severance, OCI
Expected volatility
Total fair value
Total Fair Value
Fair value
Lease liabilities
Lease debts
Total lease liabilities
Intangible assets other than goodwill
Intangible assets other than goodwill at end of period
Intangible assets other than goodwill at beginning of period
Intangible assets
Total intangible assets other than goodwill
Financial liabilities with contingent features [axis]
Accruals and deferred income including contract liabilities.
Accruals And Deferred Income Including Contract Liabilities [Line Items]
Proportion of voting rights held in associate
Voting rights held in associate
Amended and restated agreement.
Amended And Restated Agreement [Member]
Current value added tax payables
VAT Payables
Fair value at measurement date share options granted per share.
Fair Value at Measurement Date Share Options Granted Per share
Grant date share fair value
Revenue and other operating income
Revenues and other income
Total revenues and other income
External revenues and other income
Weighted average exercise price of share options exercisable exercised in share based payment arrangements.
Weighted Average Exercise Price Of Share Options Exercisable Exercised In Share Based Payment Arrangements
Weighted- average exercise price per share, exercised
Warrant exercise price
Warrant Exercise price
Exercise price
Cash and cash equivalent.
Cash and Cash Equivalent [member]
Cash and Cash Equivalents [member]
Disclosure of non-adjusting events after reporting period [abstract]
Adjustments for income tax expense
Income tax
Fair value of expected volatility amount plus five percentage.
Fair Value of Expected Volatility Amount Plus Five Percentage
Expected volatility +5%
Subsidiaries [domain]
Disclosure of transactions between related parties [line items]
Attribution of expenses by nature to their function [domain]
European Investment Bank Loan Tranche B.
European Investment Bank Loan - Tranche B [Member]
Provision for tax litigation.
Provision For Tax Litigation
Provision for tax litigation, Ending balance
Provision for tax litigation, Beginning balance
Provision for tax litigation, Biginning balance
Disclosure of non-adjusting events after reporting period [line items]
Bpifrance.
Bpifrance [Member]
BPI [Member]
Provisions for termination benefits other comprehensive income current provisions.
Provisions for termination benefits other comprehensive income current provisions
Current provisions OCI
Proportion of ownership interest in subsidiary
Ownership interest in subsidiary
Ownership interest
Milestone Payment
Milestone payment
Milestone payment
Revenue
External revenues
Total revenues
Revenues
Allocation of prior period gain (loss)
Allocation Of Prior Period Gain (Loss)
Allocation of prior period loss
Standalone statutory loss
The number of additional potential shares due to change in conversation ratio of stock options outstanding in share-based payment arrangements.
Number Of Additional Shares Due To Change In Conversation Ratio Share Based Payment Arrangement
Option outstanding, change in conversion ratios
Disclosure of financial assets and liabilities table.
Disclosure Of Financial Assets And Liabilities [Table]
Disclosure Of Financial Assets And Liabilities [Table]
Commercial litigation amounts used during the period.
Commercial Litigation Amounts Used During The Period
Commercial litigation, Amounts used during the period
Description of accounting policy for segment reporting [text block]
Segment reporting
Cash flows from (used in) operating activities
Net cash flows from (used in) operating activities
Net cash used in operating activities
European Investment Bank Loan Tranche A.
European Investment Bank Loan - Tranche A [Member]
Liabilities
Liabilities at end of period
Liabilities at beginning of period
Total liabilities
Liabilities
TOTAL LIABILITIES
Deferred expenses and other current assets.
Deferred Expenses And Other Current Assets
Deferred expenses and other current assets
Other operating expenses
Other Operating Expenses
Other operating expenses
Increase (decrease) through net exchange differences, other provisions
OCI
Non Current provisions other comprehensive income.
Non Current provisions other comprehensive income
Non current provisions OCI
Disclosure of Scope of consolidation and non-consolidated entities.
Disclosure Of Scope Of Consolidation and Non-Consolidated Entities [Abstract]
Transaction costs.
Transaction Costs
Transaction costs
Transaction costs disbursed in cash
Provisions [abstract]
Provisions for termination benefits other comprehensive income Non-current provisions.
Provisions for termination benefits other comprehensive income Non-current provisions
Non current provisions OCI
Impairment loss
Impairment of assets
Convertible Notes
Convertible Notes [Member]
Number of share options change in conversion ratios in sharebased payment arrangement.
Number Of Share Options Change In Conversion Ratios In Sharebased Payment Arrangement
Option outstanding, change in conversion ratios
Number of operating and reportable segments.
Number of Operating and Reportable Segments
Number of operating and reportable segments
Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [Domain]
Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount.
Current financial assets and cash and cash equivalent.
Current Financial Assets And Cash And Cash Equivalents
Current financial assets and cash and cash equivalents
Current deferred income including current contract liabilities
Deferred income and contract liabilities
Total Deferred revenue and contract liabilities
Deferred revenues and contract liabilities
Additions other than through business combinations, property, plant and equipment
Additions
Miscellaneous other operating expense
Other operating expenses
Adjustments for provisions
Provisions
Threshold percentage of ownership in outstanding common stock to enact indemnification agreement.
Threshold Percentage Of Ownership In Outstanding Common Stock To Enact Indemnification Agreement
Threshold percentage of ownership in outstanding common stock to enact indemnification agreement
Amendment Flag
Amendment Flag
Income loss.
Income (loss) [member]
Disclosure of share capital, reserves and other equity interest [text block]
Share capital and premium related to the share capitals
Percentage of fair market value.
Percentage Of Fair Market Value
Percentage of market value
Disclosure of detailed information about property, plant and equipment [line items]
Disclosure of detailed information about property, plant and equipment [line items]
Interest expense for financial liabilities not at fair value through profit or loss
Interest on financial liabilities
Interest on financial liabilities
Major Shareholders [Axis]
Major shareholders.
Borrowings by name [domain]
Classes of intangible assets and goodwill [axis]
Classes of intangible assets and goodwill [axis]
Number of other equity instruments forfeited in share-based payment arrangement
Option outstanding, forfeited, cancelled or expired
Categories of related parties [domain]
NORTH CAROLINA
Raleigh, North Carolina [Member]
Collaboration Agreement Payment Reallocated.
Collaboration Agreement Payment Reallocated
Collaboration agreement payment reallocated
Major customers [axis]
Current restricted cash and cash equivalents
Restricted cash
Short term restricted cash
Right-of-use assets [member]
Right-of-Use Asset
The amount of revenue from collaboration agreements.
Revenue From Collaboration Agreements
Collaboration agreements
Collaboration agreements
Revenue from collaboration agreements
Retained earnings, profit (loss) for reporting period
Net income (loss)
Weighted average fair value at measurement date, share options granted
Weighted-Average fair values of stock options granted
Cellectis, Inc. [Member]
Cellectis Inc [Member]
Cellectis [member]
Cellectis, Inc. [Member]
Schedule of outstanding balances with other major shareholders explanatory [Table Text Block]
Schedule of outstanding balances with other major shareholders explanatory.
Schedule of outstanding balances with other major shareholders
Amendment agreement one.
Amendment Agreement One [Member]
Amendment Agreement One [Member]
Increase (decrease) through transfers, right-of-use assets
Reclassification
The method used to estimate the fair value of an asset or a liability.
Valuation Method
Valuation method
Later than five years [member]
More than Five Years [member]
Warrants grant date.
Warrants Grant Date
Grant date
Ordinary shares issued
Ending balance, shares
Beginning balance, shares
Number of shares issued
Total number of shares issued
Number of shares to be issued
Provision used, other provisions
Provision used, other provisions
Amounts used during the period
Unobservable inputs [axis]
Proceeds from sale of ordinary shares.
Proceeds From Sale Of Ordinary Shares
Proceeds from sale of ordinary shares
Disclosure of income tax [text block]
Disclosure of Income Tax
Schedule disclosing information related to details of non-current financial assets and other non-current assets.
Schedule Disclosing Information Related to Details of Non-current Financial Assets and Other Non-current Assets [Text Block]
Summary of Non-current Financial Assets and other non-current assets
The decrease in contract liability balances resulting from the transfer of goods or services to customers.
Decrease due to Revenue Recognition, Contract Liabilities
Decrease due to revenue recognition
Trade and other current receivables [abstract]
Document Type
Document Type
Rights, preferences and restrictions attaching to class of share capital
Conversion ratio
Conversion ratio description
Stock option.
Stock Option 1 [Member]
Stock options [member]
Weighted average exercise price of share options exercisable forfeited or expired in share based payment arrangements.
Weighted Average Exercise Price Of Share Options Exercisable Forfeited Or Expired In Share Based Payment Arrangements
Weighted- average exercise price per share, forfeited or expired
Weighted- average exercise price per share, forfeited or expired
Cash flows from (used in) investing activities
Net cash flows from (used in) investing activities
Net cash from (used in) investing activities
Disclosure of material accounting policy information [text block]
Accounting principles
Disclosure of other current liabilities [text block]
Other current liabilities
Entity Central Index Key
Entity Central Index Key
Bottom of range [member]
Bottom of Range [member]
The increase (decrease) in contract liability balances resulting from changes in foreign exchange rates.
Increase (decrease) Through Changes in Foreign Exchange Rates, Contract Liabilities
Revenue from positive foreign exchange impact, partially offset
Miscellaneous other operating income
Other operating income
Cytovia agreement.
Cytovia Agreement [Member]
Cytovia Agreement [Member]
Provision for tax litigation additions.
Provision For Tax Litigation Additions
Provision for tax litigation, Additions
Geographical areas [axis]
Geographical areas [axis]
Increase (decrease) in working capital
Change in working capital
Current financial assets.
Current Financial Assets [member]
Current Financial Assets [member]
Borrowings
Total borrowings
Borrowings
Aggregate credit facility
Aggregate credit facility.
Agreement one.
Agreement One [Domain]
Disclosure of basis of consolidation and material accounting policy information explanatory.
Disclosure Of Basis Of Consolidation And Material Accounting Policy Information Explanatory
Basis for preparation
Collaboration agreement.
Collaboration Agreement [domain]
Current Portion of State-Guaranteed Loan
Current Portion of State-Guaranteed Loan [Member]
Associates [domain]
Provisions for termination benefits non-current provisions.
Provisions For Termination Benefits Non-current provisions
Non current provisions Ending balance
Non current provisions beginning balance
Operating expense.
Operating Expense [Abstract]
Operating expenses
Retained earnings [member]
Retained Earnings (Deficit) [member]
Depreciation, amortisation and impairment loss (reversal of impairment loss) recognised in profit or loss
Total depreciation, amortisation and impairment loss (reversal of impairment loss) recognised in profit or loss
Depreciation & impairment expense
Depreciation expense
The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualized standard deviation of the continuously compounded rates of return on the share over a period of time.
Expected Volatility
Categories of financial assets [domain]
Total Financial liabilities and lease debts
Financial Liabilities And Lease Debts
Financial liabilities and lease debts.
The weighted average fair value at the measurement date of other equity instruments (ie other than share options) expired or forfeited in a share-based payment arrangement. [Refer: Weighted average [member]"
Weighted Average Fair Value At Measurement Date Other Equity Instruments Forfeited
Weighted average exercise price per share, Cancelled
Share issuance price.
Share Issuance Price
Share issuance price
Receivables.
Receivables1 [abstract]
Employees.
Employees [Member]
Tranche A Warrants.
Tranche A Warrants [Member]
Related party transactions [abstract]
Current Fiscal Year End Date
Current Fiscal Year End Date
Current assets other than non-current assets or disposal groups classified as held for sale or as held for distribution to owners
Total current assets
Disclosure of interests in consolidation and non-consolidated entities.
Disclosure of interests in Consolidation and Non-Consolidated Entities [text block]
Scope of consolidation and non-consolidated entities
Other operating income
Other Operating Income1
Other operating income
Increase Decrease in interest income from cash, cash equivalents and financial assets
Increase (decrease) in interest income from cash, cash equivalents and financial assets.
Increase (decrease) in interest income earned on cash, cash equivalents and financial assets
Astra Zeneca.
Astra Zeneca [Member]
AstraZeneca [member]
Expenses by nature [abstract]
Operating expenses
Other non-current financial liabilities
Non-current financial liabilities
Equity investments [member]
Disclosure of impairment loss and reversal of impairment loss [abstract]
Types of financial liabilities [domain]
Increase in personnel expenses
Increase In Personnel Expenses
Increase in personnel expenses
Current liabilities
Current liabilities
Total current liabilities
Current liabilities
Other non-current financial liabilities.
Other non-current financial liabilities [member]
Other Non-Current Financial Liabilities [member]
Warrants [member]
Warrants [Member]
Geographical [Axis]
Class Of Warrants Or Right [Axis]
Additional provisions, other provisions
Additions
Total additional provisions, other provisions
Agreement two
Agreement Two [Axis]
Adjustments for increase (decrease) in deferred revenue and contract liabilities to reconcile profit (loss) to net cash flows provided by (used in) operating activities.
Adjustments For Increase Decrease In Deferred Revenue And Contract Liabilities
Decrease in deferred revenues and contract liabilities
Finance income (cost)
Net financial gain (loss)
Net Financial gain (loss)
Net Financial gain (loss)
Non-adjusting events after reporting period [axis]
Disclosure of trade and other receivables [text block]
Disclosure of Trade Receivables
Disclosure of revenue and other income explanatory.
Disclosure Of Revenue And Other Income Explanatory [TableTextBlock]
Revenues By Country of Origin and Other Income
Classes of financial liabilities [domain]
Disclosure of expected impact of initial application of new standards or interpretations [line items]
Disclosure of changes in accounting estimates [line items]
Share price warrants.
Share Price Warrants
Share price
Short-term deposits, not classified as cash equivalents
Current financial assets
Current lease debts [Member]
Current lease debts [Member]
Current Lease Debts [member]
The amount of Provisions for employee litigation and severance additions.
Provisions for employee litigation and severance additions
Employee litigation and severance, Additions
Joint research and collaboration agreement, initial investment agreement, subsequent investment agreement.
Joint Research And Collaboration Agreement Initial Investment Agreement Subsequent Investment Agreement [Member]
AZ JRCA, IIA and SIA [Member]
Non-current financial liabilities
Non-current financial liabilities
Total non-current financial liabilities
Borrowings
Fair value of warrants.
Fair value
Fair value of warrants
Fair value of pre funded warrants
Disclosure of detailed information about financial instruments [text block]
Financial assets and liabilities
Agreement Axis and License.
Agreeement [Axis]
Classes of liabilities [axis]
Interest paid, classified as financing activities
Interest expense
Interest paid
Interest paid on financial debts
Weighted average exercise price of share options forfeited in share-based payment arrangement
Weighted average exercise price per share, cancelled, forfeited or expired
Weighted average exercise price per share, forfeited or expired
Range [axis]
Range [axis]
Other comprehensive income that will not be reclassified to profit or loss net of tax from continuing operations.
Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Net Of Tax From Continuing Operations
Other comprehensive income (loss) that will not be reclassified subsequently to income or loss from continued operations
Basis for preparation
Disclosure of basis of preparation of financial statements accounting policy Information explanatory
The disclosure of the basis used for the preparation of the financial statements.
Disclosure of offsetting of financial liabilities [line items]
Disclosure of offsetting of financial liabilities [line items]
Disclosure of offsetting of financial liabilities [line items]
Option exercisable, exercised
Number of exercisable share options exercised in share based payment arrangement.
Number Of Exercisable Share Options Exercised In Share Based Payment Arrangement
Option Outstanding, exercised
Shares, Vested
Forfeited or Expired
Warrants outstanding, exercised
Option outstanding, exercised
Cash flows from (used in) investing activities [abstract]
Cash flows from investment activities
Shares entitlement per option.
Shares Entitlement per Option
Share entitlement per option
Segments [axis]
other subsidies amount.
Other Subsidies Amount
Other subsidies and other
Adjustments for decrease (increase) in trade and other receivables
Decrease (increase) in trade receivables and other current assets
Weighted average exercise price of share options exercisable in share-based payment arrangement
Weighted- average exercise price per share, ending balance
Weighted- average exercise price per share, beginning balance
Remeasurement of the contractual cash flows [member]
Remeasurement of the contractual cash flows.
Remeasurement of the Contractual Cash Flows [Member]
Trade and other receivables [abstract]
Profit (loss), attributable to ordinary equity holders of parent entity
Profit (loss), attributable to ordinary equity holders of parent entity, used in calculating basic earnings per share
Net loss attributable to shareholders of Cellectis ($ in thousands)
Disclosure of financial liabilities [line items]
Calyxt Inc.
Calyxt Inc [Member]
Calyxt Inc. [Member]
Interest received, classified as operating activities
Interest received
Financial liabilities, at fair value
Fair value
Fair value of financial liabilities
Disclosure of terms and conditions of share-based payment arrangement [table]
Disclosure of terms and conditions of share-based payment arrangement [table]
Number of shares entitled per option.
Number Of Shares Entitled Per Option
Share entitlement per option
Current loans received and current portion of non-current loans received
Current liability of loan
Loan outstanding balance
Classes of financial liabilities [axis]
Classes of financial liabilities [axis]
Number of other equity instruments granted in share-based payment arrangement
Number of options granted
Option outstanding, granted
Earnings per share [abstract]
Basic / Diluted net income (loss) per share attributable to shareholders of Cellectis
Lease agreement term.
Lease Agreement Term
Lease agreement term
Disclosure of current financial assets and cash and cash equivalents.
Disclosure Of Current Financial Assets And Cash And Cash Equivalents [Line Items]
Disclosure of current financial assets and cash and cash equivalents [line items]
Disclosure of number and weighted average remaining contractual life of outstanding share options [text block]
Summary of Information on Stock Option Activity
Provisions for retirement indemnities amounts used during the period.
Provisions For Retirement Indemnities Amounts Used During The Period
Retirement indemnities , Amounts used during the period
Increase decrease in trade receivables
Increase (decrease) in trade receivables
Decrease in trade receivables
Disclosure of information about assumptions used and valuation results.
Disclosure of information about assumptions used and valuation results [text block]
Summary of Assumptions Used and Estimated Fair Value
Unobservable inputs [domain]
Disclosure of Number Of Outstanding Option Weighted Average Exercise Price and Weighted Average Remaining Contractual Life Explanatory
Disclosure of number of outstanding option weighted average exercise price and weighted average remaining contractual life explanatory.
Summary of Information on Stock Option Activity
Schedule of Breakdown Of Right Of Use Assets [Abstract].
Schedule of Breakdown Of Right Of Use Assets [Abstract]
Disclosure of property, plant and equipment [text block]
Property, plant and equipment
Comprehensive income, attributable to owners of parent
Attributable to shareholders of Cellectis
Total comprehensive income, attributable to owners of parent
Adjustments for finance income (cost)
Net financial loss (gain)
Disclosure of disaggregation of revenue from contracts with customers [text block]
Revenues by Nature
Consolidated operations.
Consolidated operations [abstract]
Cellectis.
Cellectis [Member]
Cellectis [member]
Cellectis [Member]
Current derivative financial assets
Derivatives
Exercise price, share options granted
Exercise price
Disclosure of basis of consolidation [text block]
Information concerning the Group's Consolidated Operations
Scope of consolidation and non-consolidated entities
Disclosure of detailed information about property, plant and equipment [text block]
Details of Property, Plant and Equipment
Disclosure of impairment of assets [text block]
Impairment tests
Increase In Financial Income
Increase in financial income.
Increase in financial income
Option vesting period.
Option Vesting Period
Vesting period, years
Lease option to extend lease agreement.
Lease Option To Extend Lease Agreement
Lease option to extend lease agreement.
Lease option to extend lease agreement
Terms of repayment.
Terms of Repayment
Terms of repayment
Types of warrants [Axis]
Types of warrants [Axis]
Decrease in revenues
Increase Decrease Revenues
Increase decrease revenues.
Research Tax Credit financing
Research Tax Credit Financing [Member]
Disclosure of reconciliation of liabilities arising from financing activities [abstract]
Financial Institution [Axis]
Disclosure of financial liabilities [table]
Wages and salaries
Wages and salaries
The amount of commercial litigations.
Commercial Litigations
Commercial litigation, Ending balance
Commercial litigation, Beginning balance
Proceeds from issuing shares and other equity instruments net of transaction costs
Proceeds from issuing shares and other equity instruments net of transaction costs.
Proceeds from the issuance of share capital and other equity instruments after deduction of transaction costs
The number of additional potential shares due to change in conversation ratio of stock options outstanding in share-based payment arrangements.
Number of Additional Shares Due to Change in Conversation Ratio, Share-based Payment Arrangement
Option outstanding, change in conversion ratios
Equity and liabilities
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY
Disclosure of information about consolidated and non-consolidated structured entities.
Disclosure Of Information About Consolidated And Non-consolidated Structured Entities [Table]
Foreign exchange loss
Foreign exchange loss
Foreign exchange losses
Foreign exchange losses
Agreement Axis
Agreement [Axis]
Types of antidilutive instruments [domain]
Vesting Of Free Shares And Stock Option Exercises Value
The increase (decrease) in shareholders' equity through the issue of equity instruments resulting from the vesting of free shares and the exercises of stock-options granted to employees and directors in share-based payment arrangements.
Exercise of share warrants, employee warrants, stock-options and free-shares vesting, amount
Finance income
Financial income
Financial income
Document Information [Line Items]
Adjustments for share-based payments
Expenses related to share-based payments
Adjustments for share-based payments, Total
Expected volatility less five percent.
Expected Volatility Less Five Percent [Member]
Expected volatility -5% [Member]
Non-current financial liabilities.
Non-current financial liabilities [member]
Other non current financial liabilities [member]
Disclosure of Number and Grant Date Fair Value of Other Equity Instruments Explanatory
The number of outstanding equity instruments, other than share options, granded in share-based payment arrangements, and the related weighted average fair value at the measurement date.
Number and Weighted Average Fair Value at Measurement Date, Other Equity Instruments Granted
Warrant expiration date.
Warrant Expiration Date
Expiration date
Significant unobservable input, liabilities
Percentage of grant and refundable advance
Collaboration agreement upfront payment received
Collaboration Agreement Upfront Payment Received
Collaboration agreement, upfront payment received
Non-current financial assets
Non-current financial assets
Non current financial assets
Provisions for retirement indemnities other comprehensive income.
Provisions For Retirement Indemnities Other Comprehensive Income
Retirement Indemnities , OCI
Percentage of debt repayment terms
Percentage of debt repayment terms
The risk-free rate represents the interest an investor would expect from an absolutely risk-free investment over a specified period of time.
Risk Free Interest Rate
Risk-free interest rate
Risk free rate
Other comprehensive income, before tax, gains (losses) on remeasurements of defined benefit plans
Total other comprehensive income, before tax, gains (losses) on remeasurements of defined benefit plans
Actuarial gains (losses)
Provisions for retirement indemnities additions.
Provisions For Retirement Indemnities Additions
Retirement indemnities , Additions
Current lease liabilities
Current lease debts
Lease debts
Clinical And Rd Agreements Member
Clinical And RD Agreements [Member]
Clinical & Research and Development agreements [member]
Deferred income including contract liabilities
Deferred income and contract liabilities
Total deferred income and contract liabilities
Classes of share capital [domain]
Long-term deposits
Non-current financial assets
Deposit
The fair value of the Company's common shares.
Company share price
Share price
Defined benefit plans [domain]
Total upfront payments
Total upfront payments
Disclosure of share-based payment arrangements [text block]
Non-cash stock-based compensation
Lease remaining term.
Lease Remaining Term
Lease remaining period
Disclosure of provisions [text block]
Provisions
Disclosure of terms and conditions of share-based payment arrangement [abstract]
Expense from share-based payment transactions with employees
Share based payment expense
Share-based compensation expense
Non-cash stock based compensation expense
Other provision for charges during the period.
Other Provision For Charges During The Period
Other provision for charges, During the period
Reserve of exchange differences on translation [member]
Currency Translation Adjustment [member]
Social security contributions on stock option grants.
Social Security Contributions On Stock Option Grants
Social charges on stock option grants
Social charges on stock option grants
Classes of share capital [axis]
Classes of share capital [axis]
Types of share-based payment arrangements [domain]
Variable consideration amount
Variable consideration amount.
Fair value of expected volatility amount less five percentage.
Fair Value of Expected Volatility Amount Less Five Percentage
Expected volatility -5%
Provisions for termination benefits during the period non-current provisions.
Provisions For Termination Benefits During The Period Non-current provisions
Non current provisions Amounts used during period
Major customers [domain]
Disclosure of financial assets and liabilities.
Disclosure of Financial Assets And Liabilities [Line Items]
Disclosure of financial assets and liabilities [line items]
Increase (decrease) in non-current research tax credit receivables
Increase (decrease) in non-current research tax credit receivables
Increase (decrease) in non-current research tax credit receivables.
Other financial liabilities
Financial liabilities
Other financial liabilities
Percentage of financing tax receivable related to research tax credit
The percentage of the certain Research Tax Credit Receivables subject to a prefinancing.
Financing tax receivable percentage
Interest expense on lease liabilities
Interest on lease liabilities
The enitre disclosure of non-current financial assets explanatory.
Disclosure of Non-current Financial Assets Explanatory [Text Block]
Non-current financial assets
Other expenses, by nature
Other expenses
Other
Other expenses
Beginning balance
Equity attributable to owners of parent
Total equity attributable to owners of parent
Ending balance
Capital commitments [abstract]
Current financial assets
Current financial assets
Deposit
Current financial assets
Adjustments for increase decrease in deferred revenues and contract liabilities.
Adjustments for increase decrease in deferred revenues and contract liabilities
Increase in deferred revenues and contract liabilities
Initial fair value of loan.
Initial Fair Value Of Loan
Initial fair value of the loan
Provision for tax litigation member.
Provision For Tax Litigation [Member]
Provision for tax litigation [Member]
Increase In Selling General And Administrative Expenses
Increase In Selling General And Administrative Expenses
Increase in selling, general and administrative expenses
Cellectis biologics, Inc.
Cellectis Biologics Inc [Member]
Cellectis Biologics, Inc. [Member]
License and Collaboration Agreements [Member]
License and Collaboration Agreements [Member]
License and Collaboration Agreements [Member]
Other non-current financial assets
Other financial assets
Selling, general and administrative expense
Total selling, general and administrative expense
Selling, general and administrative expenses
Total selling, general and administrative expenses
Derivatives by name.
Derivatives By Name [Axis]
Share premium
Premiums related to the share capital
Disclosure of events after reporting period [text block]
Subsequent events
Number of share options exercisable in share-based payment arrangement
Option exercisable, ending balance
Option exercisable, beginning balance
The amount of provisions for employee litigation and severance reversal.
Provisions for employee litigation and severance reversal
Employee litigation and severance, Reversals
Fixtures, fittings and other equipment.
Fixtures, Fittings and Other Equipment [Member]
Number of share options outstanding in share-based payment arrangement
Option outstanding, ending balance
Option outstanding, beginning balance
Expected volatility warrants.
Expected Volatility Warrants
Expected volatility
Disclosure of Information concerning groups consolidated operartions explanatory.
Disclosure of Information concerning Groups Consolidated Operartions Explanatory
Information concerning the Group's Consolidated Operations
Current value added tax receivables
VAT receivables
Tax (other than income tax and value added tax) and social receivables current.
Tax and social receivables current
Tax and social receivables
Non-current assets
Non-current assets
Total non-current assets
Share options [member]
Stock options [member]
Other current financial liabilities.
Other Current Financial Liabilities [Member]
Disclosure of changes in accounting estimates [abstract]
Levels of fair value hierarchy [axis]
Addition for current provision.
Addition For Current Provision
Current provision additions
Number of warrant granted
Number of options granted
Measurement [domain]
The number of additional potential shares due to change in conversation ratio of exercisable options in share-based payment arrangements.
Number of Additional Shares Due to Change in Conversation Ratio, Exercisable Options
Option exercisable, change in coversion ratios
Average life of options.
Average Life of Options
Average life of options
Provisions for termination benefits current provisions.
Provisions For Termination Benefits current provisions
Current provisions Ending balance
Current provisions beginning balance
Principal.
Principal [Member]
Classes of commitments.
Classes of commitments [axis]
Disclosure of classes of share capital [line items]
Disclosure of classes of share capital [line items]
Later than one year and not later than three years [member]
1-3 years [member]
Provisions for termination benefits during the period current provisions.
Provisions For Termination Benefits During The Period current provisions
Current provisions Amounts used during period
Statement of changes in equity [abstract]
Net income (loss)
Net income (loss)
Net loss for the period
Net loss
Licence fee income
Licenses
Foreign exchange gain
Foreign exchange gains
Cash on hand
Cash and bank accounts
Document Period End Date
Document Period End Date
Current tax liabilities
Income tax payables
Other current assets
Other current assets
Total other current assets
Other current financial assets (deposits)
Debt securities [member]
Associates [axis]
Categories of related parties [axis]
Categories of related parties [axis]
Finance income expense [abstract].
Finance income expense [abstract]
Disclosure of non-adjusting events after reporting period [table]
Disclosure of trade receivables.
Disclosure of trade receivables [line items]
Provisions for termination benefits reversals non-current provisions.
Provisions For Termination Benefits Reversals Non-current provisions
Non current provisions Reversals
Disclosure of detailed information about current financial assets and cash and cash equivalents explanatory.
Disclosure Of Detailed Information About Current Financial Assets And Cash And Cash Equivalents Explanatory [Text Block]
Summary of Current Financial Assets and Cash and Cash Equivalents
Right-of-use assets
Ending balance
Beginning balance
Right-of-use assets
Right-of-use assets
Deferred revenue including upfront payment.
Deferred Revenue Including Upfront Payment
Deferred revenue including upfront payment
Commercial litigation.
Commercial litigation [member]
Commercial litigation [Member]
Financial liabilities with contingent features [domain]
Other income
Other income
Other income
External other income
Personnel expenses.
Personnel Expenses [member]
Personnel Expenses [Member]
Financial assets, at fair value
Fair value
Total current financial liabilities and lease debts.
Total Current Financial Liabilities And Lease Debts
Total current financial liabilities and current lease debts
Total current financial liabilities and current lease debts
Issued capital
Total issued capital
Share capital
Financial assets outside scope of IFRS 7, class [member]
Investee.
Investee [Domain]
The weighted average fair value at the measurement date of outstanding equity instruments other than share options. [Refer: Weighted average [member]].
Weighted average fair value at measurement date other equity instruments outstanding
Weighted average exercise price per share, ending balance
Weighted average exercise price per share, beginning balance
Income tax
Effective tax expense
Total tax expense (income)
Income tax
Tax income (expense)
Consolidated operations [line items].
Consolidated operations [line items]
Consolidated operations [line items]
BPI Refundable Advance Agreement.
BPI Refundable Advance Agreement [Member]
Property, plant and equipment, accumulated depreciation, amortisation and impairment
Property, plant and equipment, accumulated depreciation, amortisation and impairment
Accumulated depreciation and impairment at end of period
The decrease in liabilities arising from financing activities resulting from interest payments.
Decrease Through Financing Cash Flows (Interest Payment), Liabilities Arising from Financing Activities
Interest paid financial liabilities and lease debts
Disclosure of schedule of off-balance sheet commitments.
Disclosure of Schedule of Off-balance Sheet Commitments Explanatory
Schedule of Off-balance Sheet Commitments
Revenue [abstract]
Contract liabilities
Contract liabilities at end of period
Contract liabilities at beginning of period
Deferred revenues
Total contract liabilities
Disclosure Of Number And Weighted Average Exercise Prices Of Share Options and awards [Line Items]
Disclosure Of Number And Weighted Average Exercise Prices Of Share Options and awards [Line Items]
Disclosure Of Number And Weighted Average Exercise Prices Of Share Options and awards [Line Items]
Financial liability maturity.
Financial Liability Maturity
Financial liability maturity
Types of financial liabilities [axis]
Disclosure of impairment loss and reversal of impairment loss [table]
Current financial liabilities
Current financial liabilities
Total current financial liabilities
Other current payables
Other
Reversal of current provisions.
Reversal Of Current Provisions
Current provisions Reversals
Other comprehensive income, before tax, exchange differences on translation
Currency translation adjustment
Other comprehensive income, before tax, exchange differences on translation of foreign operations
Classes of financial assets [domain]
Losses on change in fair value of derivatives
Losses on change in fair value of derivatives
Loss on fair value measurement
Disclosure Of Maturities Of Financial Liabilities Explanatory [text block]
Disclosure of maturities of financial liabilities explanatory.
Remaining contractual maturities of financial liabilities
Expected dividend as percentage, share options granted
Expected dividends
Decrease in financial income.
Decrease In Financial Income
Decrease in financial income
Increase (decrease) through transfers, property, plant and equipment
Reclassification
Reclassification
Class Of Warrants Or Right [Domain]
NEW YORK
New York [Member]
Cibus, Inc.
Cibus Inc [Member]
Provisions for termination benefits additions Non-current provisions
Provisions for termination benefits additions Non-current provisions
Non current provisions additions
Classes of other provisions [axis]
Categories of non-current financial assets [abstract]
Description of presentation currency explanatory.
Description Of Presentation Currency Explanatory
Currency of the financial statements
The amount of current grant receivables.
Current subsidies receivables
Subsidies receivables
Entity File Number
Fixed interest rate.
Fixed Interest Rate
Annual rate of discounting
Weighted average fair value at measurement date other equity instrument granted.
Weighted Average Fair Value At Measurement Date Other Equity Instrument Granted
Weighted average exercise price per share, granted
Cover [Abstract]
Purchases and external expenses.
Purchases And External Expenses
Purchases and external expenses
Leased equipment.
Leased Equipment [Member]
Disclosure of deferred income and contract liabilities.
Disclosure of Deferred Income and Contract Liabilities Explanatory
Investee.
Investee [Axis]
Unused provision reversed, other provisions
Unused provision reversed, other provisions
Pension, Reversals
Disclosure of quantitative information about right-of-use assets [line items]
Summary of Number of Shares Outstanding and Weighted Average Grant Date Fair Value
Disclosure of number and weighted average exercise prices of other equity instruments [text block]
Non-current Lease Liabilities
Non-current Lease Liabilities [Member]
Non Current Lease Debts [Member]
Agreements Extended Maturity Date
Agreements Extended Maturity Date
Agreements extended maturity date
Level 1 of fair value hierarchy [member]
Level 1 [member]
Disclosure of related party [text block]
Significant transactions with related parties
Related parties and other major shareholders
Current liabilities [abstract]
Current liabilities
Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]
Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]
Categories of financial liabilities [axis]
Description of vesting requirements for share-based payment arrangement
Vesting conditions
Vesting conditions
Disclosure of financial assets [abstract]
Disclosure of financial assets [abstract]
The description of inputs used in the fair value measurement of liabilities. Inputs are the assumptions that market participants would use when pricing the liability, including assumptions about risk such as the risk inherent in a particular valuation technique used to measure fair value (such as a pricing model) and the risk inherent in the inputs to the valuation technique.
Description of inputs used in fair value measurement, liabilities [Table text block]
Disclosure of assumptions and results of the warrant valuation
Trade payables.
Trade Payables [member]
Trade Payables [member]
Disclosure of number and weighted average exercise prices of share options [text block]
Summary of Information on Stock Option Activity
Executive Officers and Chairman of Board of Directors [Member]
Executive officers and chairman of board of directors.
Text Block [Abstract]
Text block1 [abstract]
Text block1 [abstract]
Counterparties [domain]
Disclosure of current financial assets and cash and cash equivalents explanatory.
Disclosure of current financial assets and cash and cash equivalents explanatory [Text Block]
Current financial assets and Cash and cash equivalents
Disclosure of earnings per share [text block]
Earnings per share
IT Licensing agreement.
IT Licensing agreement [member]
IT Licensing Agreements [Member]
Other provision for charges additions.
Other Provision For Charges Additions
Other provision for charges, Additions
Description of method of settlement for share-based payment arrangement
Valuation method
Number of shares outstanding
Balance at end, Number of shares
Balance at beginning, Number of shares
Number of shares outstanding
Subsidies receivables.
Subsidies receivables [member]
Subsidies Receivables [member]
Disclosure of terms and conditions of share-based payment arrangement [line items]
Disclosure of terms and conditions of share-based payment arrangement [line items]
Assumptions and results of the warrants valuation
Other current financial liabilities
Other current liabilities
Other current liabilities
Provision for tax litigation used during the period.
Provision for Tax Litigation Used During The Period
Provision for tax litigation, Amounts used during the period
Financial liabilities at amortised cost, category [member]
Financial Liabilities at Amortised Cost, Category [Member]
Disclosure of other current assets [text block]
Disclosure of Other Current Assets
Increase (decrease) through net exchange differences, property, plant and equipment
Translation adjustments
Financial assets at fair value through profit or loss, category [member]
Financial Assets at Fair Value Through Profit or Loss, Category [Member]
Disclosure of other receivables, prepayments and other current asset.
Disclosure of Other Receivables Prepayments and Other Current Assets [Abstract]
Disclosure of detailed information about provisions.
Disclosure Of Detailed Information About Provisions [Text Block]
Details of Provisions
The option life of share option granted.
Option Life Share Option Granted
Option life, share option granted
Other provision for charges reversals.
Other Provision For Charges Reversals
Other provision for charges, Reversals
Non current provisions during the period.
Non Current Provisions During The Period
Non current provisions Amounts used during period
Risk free interest rate, share options granted
Risk-free interest rate
Exercise of share warrants, employee warrants, stock-options and free-shares vesting, shares
Increase In Number Of Ordinary Shares Issued Due To Vesting Of Free Shares And Stock Option Exercises
The increase in the number of ordinary shares issued due to vesting of free shares and exercise of stock options granted to employees and directors in share-based payment arrangements.
Total non-current financial liabilities and non-current lease debts.
Total Non current Financial Liabilities And Non current Lease Debts
Non-current financial liabilities and non-current lease debts, Ending balance
Non-current financial liabilities and non-current lease debts, Beginning balance
Total non-current financial liabilities and non-current lease debts
Total non-current financial liabilities and non-current lease debts
Profit or loss [abstract]
Statement of financial position [abstract]
Prepaid expenses and other current assets.
Prepaid Expenses and Other Current Assets [Line Items]
Prepaid expenses and other current assets [line items]
Selling general and administrative expenses
Selling General And Administrative Expenses 1 [Member]
Selling, General and Administrative Expenses [Member]
Current assets [abstract]
Current assets
Other comprehensive income
Other comprehensive income (loss)
Total other comprehensive income (loss)
Restricted stock unit.
Restricted Stock Unit [Member]
RSU Calyxt 2017 [member]
Classes of assets [domain]
Retirement indemnities.
Retirement Indemnities [Member]
Retirement Indemnities [Member]
Weighted average exercise price of share options granted in share-based payment arrangement
Weighted average exercise price per share, granted
Current provisions other comprehensive income.
Current Provisions Other Comprehensive Income
Current provisions OCI
Components of equity [axis]
Components of equity [axis]
Types of antidilutive instruments [axis]
Increase in research and development expense
Increase in Research and Development Expense
Increase in research and development expense.
Adjustments for gain (loss) on disposals, property, plant and equipment
Net loss (income) on disposals
Cash flows from (used in) operations before changes in working capital
Operating cash flows before change in working capital
Basic earnings (loss) per share
Total basic earnings (loss) per share
Basic net income (loss) attributable to shareholders of Cellectis, per share ($ /share)
Basic net loss per share attributable to shareholders of Cellectis ($ /share)
Increase In Depreciation And Amortization Expenses
Increase In Depreciation And Amortization Expenses
Increase in depreciation and amortization expenses
At fair value [member]
Fair Value [Member]
Provisions for retirement indemnities.
Provisions For Retirement Indemnities
Retirement indemnities , Ending Balance
Retirement indemnities , Beginning Balance
Number of derivative instruments warrant granted.
Number of Derivative Instruments Warrant Granted
Number of options granted
Office and Laboratory equipment.
Office and laboratory equipment [member]
Reallocated proceeds from sale of ordinary shares.
Reallocated Proceeds From Sale Of Ordinary Shares
Reallocated proceeds from sale of ordinary shares
The weighted average per share price used as input to the option pricing model to calculate the fair value of share options granted.
Weighted Average Share Price Share Options Granted Per share
Weighted-Average fair values of stock options granted
Weighted-Average fair values of warrants granted
Adjustments for realized foreign exchange losses gains.
Adjustments For Realized Foreign Exchange Losses Gains
Realized foreign exchange gain (loss) related to operating activities
Number of warrants issued.
Number Of Warrants Issued
Number of warrants issued
Adjustments for depreciation and amortisation expense
Amortization and depreciation
Adjustments for depreciation and amortisation expense, Total
Attribution of expenses by nature to their function [axis]
Disclosure of Information About Share Based Payment Award Stock Options Valuation Assumptions Explanatory
Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, and (d) risk-free rate(s).
Summary of assumptions Vesting Details
Provisions
Ending balance
Beginning balance
Total provisions
Current provisions during the period.
Current Provisions During The Period
Current provisions Amounts used during the period
Current trade receivables
Trade receivables
Total net value of trade receivables
Total net value of trade receivables
Initial fair value amount.
Initial Fair Value Amount
Initial fair value amount
Maturity [domain]
Liabilities arising from financing activities
Financial liabilities and lease debts, Ending balance
Financial liabilities and lease debts, Beginning balance
Share price used as input to the option pricing model to calculate the fair value of share options granted.
Underlying Stock Price at Grant Date
Underlying stock price at grant date
Leased premises.
Leased Premises [Member]
Document Fiscal Year Focus
Document Fiscal Year Focus
Ordinary shares [member]
Share Capital Ordinary Shares [member]
Common Stock [Member]
Maturity [axis]
Maturity [axis]
Weighted average exercise price of share options change in conversion ratios in sharebased payment arrangement.
Weighted Average Exercise Price Of Share Options Change In Conversion Ratios In Sharebased Payment Arrangement
Weighted- average exercise price per share, Additional shares due to change in conversion ratios
Expiration Date.
Expiration Date
Expiration date
Current Lease Liabilities
Current Lease Liabilities [Member]
Current Lease Debts [Member]
Weighted average number of ordinary shares outstanding
Weighted average number of outstanding shares, used to calculate basic net result per share
Basic
Disclosure of detailed information about deferred income and contract liabilities.
Disclosure Of Detailed Information About Deferred Income And Contract Liabilities Explanatory
Details of Deferred Income and Contract Liabilities
Non Employee Warrants
Non Employee Warrants [Member]
Non Employee Warrants [Member]
Geographical areas [domain]
Disclosure of contingent liabilities [table]
Increase (decrease) in cash and cash equivalents
(Decrease) increase in cash and cash equivalents
Net increase (decrease) in cash and cash equivalents after effect of exchange rate changes
Decrease in cash and cash equivalents
Disclosure of expenses by nature [text block]
Details of Operating Expenses by Nature
Disclosure of current financial assets and cash and cash equivalents.
Disclosure of Current Financial Assets and Cash and Cash Equivalents [Table]
Disclosure of Current Financial Assets and Cash and Cash Equivalents [Table]
Level 3 of fair value hierarchy [member]
Level 3 [member]
Non-current liabilities [abstract]
Non-current liabilities
Subsidiaries [axis]
Subsidiaries [axis]
Classes of liabilities [domain]
Non current lease debts [Member]
Non current lease debts [Member]
Non Current Lease Debts [member]
Gross carrying amount [member]
Gross value [member]
Gross Value [Member]
Financial assets at amortised cost, category [member]
Financial Assets at Amortised Cost, Category [Member]
Number of other equity instruments exercised or vested in share-based payment arrangement
Option outstanding, exercised/vested
Voting agreement with cibus.
Voting Agreement with Cibus [Member]
Voting Agreement with Cibus [Member]
Subsequent investment agreement.
Subsequent Investment Agreement [Member]
Subsequent Investment Agreement (SIA) [Member]
Average effective tax rate
Effective tax rate
Total average effective tax rate
Effective income tax rate
Weighted average exercise price of share options exercised in share-based payment arrangement
Weighted average exercise price per share, exercised
Weighted average exercise price per share, exercised/vested
Interest rate, measurement input [member]
Interest Rate, Measurement Input [Member]
Share price of warrant.
Share Price Of Warrant
Share price (in euros)
Share price
Other adjustments for non-cash items
Other non-cash items
Categories of financial assets [axis]
The disclosure of the number and weighted average grant date fair value of other equity instruments (i.e. other than share options) in share-based payment arrangements.
Disclosure of number and weighted average grant date fair value of other equity Instruments Explanatory
Summary of Number of Shares Outstanding and Weighted Average Grant Date Fair Value
Counterparties [axis]
Disclosure of fair value of financial instruments [text block]
Summary of Financial Assets and Liabilities
Number of share options forfeited in share-based payment arrangement
Option outstanding, forfeited or expired
Provision for tax litigation, Reversals
Provision For Tax Litigation Reversals
Provision for tax litigation, Reversals
Property, plant and equipment by operating lease status [domain]
Liabilities [abstract]
LIABILITIES
Cash flows from (used in) financing activities [abstract]
Cash flows from financing activities
Class A convertible preferred shares.
Class A convertible preferred shares [Member]
"Class A" Convertible Preferred Shares [Member]
Preference shares [member]
Share Capital Preference Shares [Member]
Range [domain]
Statement of changes in equity [line items]
Property, plant and equipment
Ending balance
Beginning balance
Property, plant and equipment
Total property, plant and equipment
Provisions for termination benefits reversals current provisions.
Provisions For Termination Benefits Reversals current provisions
Current provisions Reversals
Primera therapeutics, Inc.
Primera Therapeutics Inc [Member]
Primera Therapeutics, Inc. [Member]
Number of share options granted in share-based payment arrangement
Number of equity instruments granted in share-based payment arrangement
Option outstanding, granted
Retained earnings, excluding profit (loss) for reporting period
Retained earnings (deficit)
The entire disclosure in details of financial liabilities and lease debts.
Disclosure of Detailed Financial Liabilities and Lease Debts Explanatory
Detail of financial liabilities and lease debts
Trade receivables [member]
Trade Receivables [member]
Weighted average exercise price of share options exercisable granted in share based payment arrangements.
Weighted Average Exercise Price Of Share Options Exercisable Granted In Share Based Payment Arrangements
Weighted- average exercise price per share, granted
Other provision for charges.
Other Provision For Charges
Other provision for charges, Ending balance
Other provision for charges, Beginning balance
Other provision for charges, Biginning balance
Classes of other provisions [domain]
Document Information [Table]
Disclosure of other provisions [line items]
Provision for tax litigation other comprehensive income.
Provision For Tax Litigation Other Comprehensive Income
Provision for tax litigation, OCI
Disclosure of detailed information about property, plant and equipment [abstract]
Calyxt.
Calyxt [Member]
Calyxt [member]
Disclosure of contingent liabilities [line items]
Total Current Financial Liabilities and Current Lease Debts
Total Current Financial Liabilities and Current Lease Debts [Member]
Current provisions
Current provisions Ending balance
Current provisions beginning balance
Current provisions
Total current provisions
Property, plant and equipment by operating lease status [axis]
Property, plant and equipment by operating lease status [axis]
Proceeds From the Repayment of Other Investments
Proceeds from the repayment of other investments.
Proceeds from the repayment of other investments
Free shares.
Free Shares [member]
Free Shares [member]
Disclosure of expected impact of initial application of new standards or interpretations [table]
Disclosure of changes in accounting estimates [table]
Disclosure of detailed information about financial instruments [abstract]
Disclosure of reconciliation of liabilities arising from financing activities [text block]
Disclosure of reconciliation of movements of liabilities to cash flows arising from financing liabilities
Purchase of financial assets measured at amortised cost, classified as investing activities
Acquisition of current financial assets
Non Executive Employees.
Non Executive Employees [Member]
Non-current derivative instruments.
Non-current derivative instruments [member]
Non-current Derivative Instruments (EIB warrants) [member]
Current provisions used during the period.
Current Provisions Used During the Period
Current provisions Amounts used during the period
Weighted average ordinary shares used in calculating basic and diluted earnings per share [abstract]
Number of shares used for computing
Buildings [member]
Building lease [member]
Depreciation, right-of-use assets
Depreciation, right-of-use assets
Depreciation expense
Disclosure of financial liabilities and lease debts.
Disclosure of financial liabilities and lease debts explanatory [text block]
Detail of financial liabilities and lease debts
Financial liabilities and lease debts
Increase (decrease) through changes in fair values, liabilities arising from financing activities
Non-cash change in fair value financial liabilities and lease debts
Class B convertible preferred shares.
Class B convertible preferred shares [Member]
"Class B" Convertible Preferred Shares [Member]
Tranche B Warrants [Member]
Tranche B Warrants [Member]
Defined benefit plans [axis]
Defined benefit plans [axis]
Disclosure of classes of share capital [table]
Disclosure of classes of share capital [table]
The portion of the research tax credit receivable which is expected to be refunded within more than twelve months after the reporting period.
Research Tax Credit Receivable Non-current
Research tax credit
Increase Decrease In Foreign Exchange Losses
Increase (decrease) in foreign exchange losses.
Increase (decrease) in foreign exchange losses
Effective interest rate of loan.
Effective Interest Rate of Loan
Effective interest rate of loan
Non-current derivative financial liabilities
Non-current derivative financial liabilities
Shares issued to the benefit of employees related free share plans
Increase In Number Of Ordinary Shares Issued Due To Vesting Of Free Shares
The increase in the number of ordinary shares issued due to vesting of free shares granted to employees and directors in share-based payment arrangements.
The increase (decrease) in liabilities arising from financing activities resulting from reclassifications between current and non-current activities.
Increase (Decrease) Through Reclassification Between Current and Non-Current, Liabilities Arising from Financing Activities
Reclassifications financial liabilities and lease debts
Increase (Decrease) in Purchases, External Expenses and Other
Increase (decrease) in purchases, external expenses and other.
Increase in purchases and external expenses
Current accrued liabilities for personnel related expenses.
Current accrued liabilities for personnel related expenses
Accruals for personnel related expenses
Trade payables
Trade payables
Trade payables
Equity [abstract]
Shareholders' equity
Provision used including provision for employee benefits.
Provision Used Including Provision for Employee Benefits
Amounts used during the period
Borrowings by name [axis]
Construction in progress [member]
Assets Under Construction [Member]
The increase (decrease) in liabilities arising from financing activities resulting from other non-cash changes.
Increase (Decrease) Through Other Non-Cash Movements, Liabilities Arising from Financing Activities
Other non-cash movements financial liabilities and lease debts
Disclosure of financial liabilities [abstract]
Expected volatility plus five percent.
Expected Volatility Plus Five Percent [Member]
Expected volatility +5% [Member]
Revenue that was included in contract liability balance at beginning of period
Revenue that was included in contract liability balance at beginning of period
Disclosure of commitments [text block]
Commitments
Off-balance sheet commitments
Assets
Assets at end of period
Assets at beginning of period
TOTAL ASSETS
Prepaid Expenses and Other Current Assets [Table]
Prepaid Expenses and Other Current Assets [Table]
Prepaid Expenses and Other Current Assets [Table]
Reversal of non current provisions.
Reversal Of Non Current Provisions
Non current provisions Reversals
Cash and cash equivalents [abstract]
The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed.
Risk Free Interest Rate Warrants
Risk free rate
Disclosure of detailed information about other current liabilities.
Disclosure of detailed information about other current liabilities [Text Block]
Summary of Other Current Liabilities
Description of accounting policy for going concern explanatory.
Description Of Accounting Policy For Going Concern Explanatory
Going concern
Number of other equity instruments outstanding in share-based payment arrangement
Option outstanding, ending balance
Option outstanding, beginning balance
Unused provisions reversed including employee benefits.
Unused Provisions Reversed Including Employee Benefits
Pension, Reversals
Adjustments for increase (decrease) in trade account payable and other current liabilities.
Adjustments For Increase (Decrease) In Trade Account Payable And other current liabilities
Decrease in trade payables and other current liabilities
Change in provisions through other comprehensive income including provisions for employee benefits.
Change in Provisions through Other Comprehensive Income Including Provisions for Employee Benefits
OCI
Disclosure of other provisions [table]
Components of equity [domain]
Types of share-based payment arrangements [axis]
Types of share-based payment arrangements [axis]
The weighted-average exercise price of exercisable options for which the conversion ratios were modified during the period.
Weighted-average Exercise Price of Additional Exercisable Options Due to Change in Conversion Ratios, Share-based Payment Arrangement
Weighted- average exercise price per share, Additional shares due to change in conversion ratios
Increase Decrease In Prepaid Expenses And Other Prepayments
Increase decrease in prepaid expenses and other prepayments.
Increase in prepaid expenses and other prepayments
Other subsidies receivables.
Other Subsidies Receivables
Other subsidies
Increase (decrease) through net exchange differences, right-of-use assets
Translation adjustments
Par value per share
Nominal value
European Investment Bank Loan
European Investment Bank Loan [Member]
European Investment Bank Loan [Member]
European Investment Bank Credit Facility [Member]
Other operating income (expense)
Other operating income and (expense)
Other operating income
Weighted average exercise price of share options outstanding in share-based payment arrangement
Weighted average exercise price per share, ending balance
Weighted average exercise price per share, beginning balance
Disclosure of cash and cash equivalents [text block]
Details of Cash and Cash Equivalents
Minimum revenue to be achieved.
Minimum revenue to be achieved
Preferred shares, conversion ratio.
Preferred Shares Conversion Ratio
Conversion ratio
Other comprehensive income, before tax, exchange differences on translation, other than translation of foreign operations
Currency translation adjustment generated by the parent company
Disclosure of quantitative information about right-of-use assets [table]
Weighted average number of outstanding shares, net of effects of dilutive potential ordinary shares
Weighted average number of outstanding shares, used to calculate diluted net result per share
Diluted
Disclosure of revenue.
Disclosure of Revenue [Table]
Disclosure of Revenue [Table]
Disclosure of indirect measurement of fair value of goods or services received, share options granted during period [text block]
Summary of assumptions Vesting Details
Average Life Options
Average life options.
Average life of options
Deferred income other than contract liabilities
Other deferred income
Non-current assets [abstract]
Non-current assets
Milestone Payment For 10 Candidate
Milestone payment for 10 candidate.
Milestone Payment For 10 Candidate
Current trade payables
Trade payables
Disclosure of finance income (cost) [text block]
Details of Financial Income and Expenses
Commercial litigation other comprehensive income.
Commercial Litigation Other Comprehensive Income
Commercial litigation, OCI
Diluted earnings (loss) per share
Total diluted earnings (loss) per share
Diluted net income (loss) attributable to shareholders of Cellectis, per share ($ /share)
Diluted net loss per share attributable to shareholders of Cellectis ($ /share)
Disclosure of reconciliation of liabilities arising from financing activities [table]
Cytovia.
Cytovia [Member]
FRANCE
France [Member]
FR
The weighted average fair value at the measurement date of other equity instruments (ie other than share options) vested in a share-based payment arrangement. [Refer: Weighted average [member]".
Weighted Average Fair Value At Measurement Date Other Equity Instrument Vested
Weighted average exercise price per share, Vested
Discount rate
Discount rate
Discount rate
Entity Registrant Name
Entity Registrant Name
Provisions for termination benefits additions current provisions.
Provisions for termination benefits additions current provisions
Current provisions additions
Non-current portion of non-current loans received
Non current liability of loan
Conditional advances
Statement of changes in equity [table]
Disclosure of trade receivables.
Disclosure of trade receivables [table]
Disclosure of financial assets [line items]
Provisions for retirement indemnities reversals.
Provisions For Retirement Indemnities Reversals
Retirement Indemnities , Reversals
Increase (decrease) in contract liabilities.
Increase (Decrease) in Contract Liabilities
Increase in deferred revenue
Decrease in deferred revenue
Amendment Description
Gauranteed borrowing amount percentage.
Gauranteed Borrowing Amount Percentage
Guaranteed borrowing amount, percentage
Short-term deposits, classified as cash equivalents
Cash and bank accounts
Fixed bank deposits
Description of accounting policy for transactions with AstraZenea explanatory.
Description Of Accounting Policy For Transactions With AstraZenea Explanatory
Accounting treatment of transactions with AstraZeneca
Statement of comprehensive income [abstract]
Disposals and retirements, property, plant and equipment
Disposal
Total disposals and retirements, property, plant and equipment
Depreciation And Amortization Expenses Inclusive Right Of Use Amortization
Depreciation And Amortization Expenses Inclusive Right Of Use Amortization
Depreciation and amortization expenses (incl. right of use amortization)
It licensing agreements member.
It Licensing Agreements [Member]
IT Licensing Agreements [Member]
Share premium [member]
Premiums Related to Share Capital [member]
Equity
Balance at end of year
Beginning balance
Total shareholders' equity
European Investment Bank Loan Tranche C.
European Investment Bank Loan - Tranche C [Member]
Classes of property, plant and equipment [domain]
Total Non-Current Financial Liabilities and Non-Current Lease Debts
Total Non-Current Financial Liabilities and Non-Current Lease Debts [Member]
Disclosure of detailed information about non-current financial assets explanatory.
Disclosure of Detailed Information about Non-current Financial Assets Explanatory [Text Block]
Summary of Non-current Financial Assets
Disclosure of government grants [text block]
Disclosure of Subsidies Receivables
Non-current financial assets.
Non-current financial assets [member]
Non-current Financial Assets [member]
Remaining contractual life of option
Remaining Contractual Life Of Option
Contractual life of options
Increase in borrowings
Secured Borrowings
Proceeds from the issuance of share capital and other equity instruments after deduction of transaction costs
The amount of revenue from products and services.
Revenue From Products Services
Products & services
Miscellaneous current liabilities [abstract]
Expense from share-based payment transactions
Share-based compensation expense
Total expense from share-based payment transactions
Non-current provisions
Non current provisions Ending balance
Non current provisions beginning balance
Non-current provisions
Total non-current provisions
Decrease (increase) in financial Expenses.
Increase Decrease In Financial Expenses
Decrease /increase in financial Expenses
Other finance cost
Other financial expenses
Other financial expenses
Accumulated impairment [member]
Allowance for expected credit losses
Number of cash generating unit
Number of cash generating unit
Number of cash generating unit
Other financial income
Other finance income
Disclosure of detailed information about property, plant and equipment [table]
Disclosure of detailed information about property, plant and equipment [table]
Details of Property, Plant and Equipment
Additional provisions including provisions for employee benefits.
Additional Provisions including Provisions for Employee Benefits
Additions
Accumulated depreciation, amortisation and impairment [member]
Accumulated depreciation and impairment [member]
Accumulated Depreciation and Impairment [Member]
Technical equipments.
Technical Equipments [Member]
Technical Equipment [Member]
Expiration period of stock option plan.
Expiration Period of Stock Option Plan
Stock option expire, years
Adjustments for decrease (increase) in subsidies and tax receivables to reconcile profit (loss) to net cash flows provided by (used in) operating activities.
Adjustments for Decrease (Increase) in Subsidies and Tax Receivables
Increase in subsidies and tax receivables
Disclosure of sensitivity analysis on the expected volatility [table text block]
Disclosure of sensitivity analysis on the expected volatility explanatory
Disclosure of sensitivity analysis on the expected volatility
The amount of provisions for employee litigation and severance, amounts used during the period.
Provisions for employee litigation and severance amounts used during the period
Employee litigation and severance, Amounts used during the period
Date of grant of share-based payment arrangement
Grant date
Purchase of property, plant and equipment, classified as investing activities
Acquisition of property, plant and equipment
Purchase of property, plant and equipment
Decrease in non-current restricted cash.
Decrease in Non-Current Restricted Cash
Decrease in non-current restricted cash
Disclosure Or Related Party And Major Shareholders Explanatory
Disclosure or related party and major shareholders explanatory.
Related parties and other major shareholders
Research and development expense
Research and development expenses
Total research and development expenses
Repayments of borrowings, classified as financing activities
Repayments of borrowings
Repaid of loan
Repayments of financial liabilities
The percentage of an expected dividend used to calculate the fair value of share options granted.
Expected Dividend As Percentage
Expected dividends
Non-current liabilities
Non-current liabilities
Total non-current liabilities
Statement of cash flows [abstract]
French Resident Employees.
French Resident Employees [Member]
European investment bank warrants [member]
European investment bank warrants [member]
European Investment Bank Warrants [Member]
Lease remaining period.
Lease Remaining Period
Lease remaining period
The amount of commercial litigations reversal.
Commercial litigations reversal
Commercial litigation, Reversals
Non-current restricted cash and cash equivalents
Restricted cash
Initial term for selection of candidate products.
Initial Term For Selection Of Candidate Products
Initial term for selection of candidate products
Fair value of ordinary shares.
Fair Value Of Ordinary Shares
Fair value of ordinary shares
Borrowings, interest rate
Interest rate
Fixed interest rate
Other provision for charges member.
Other Provision For Charges [Member]
Other provision for charges [Member]
Classes of assets [axis]
Classes of assets [axis]
Non-adjusting events after reporting period [domain]
Subsidies receivables current.
Subsidies receivables current
Total subsidies receivables
Refund received due to reversal of a tax litigation provision
Refund received due to reversal of a tax litigation provision
Employee litigation and severance.
Employee litigation and severance [member]
Employee Litigation and Severance [Member]
Cash flows from (used in) operating activities [abstract]
Cash flows from operating activities
Expected volatility, share options granted
Expected volatility
Expected volatility
Other provision for charges other comprehensive income.
Other Provision For Charges Other Comprehensive Income
Other provision for charges, OCI
Increase In Non Cash Gains Recognized From Fair Value Measurements
Increase in non-cash gains recognized from fair value measurements.
Increase in non-cash gains recognized from fair value measurements
The amount of commercial litigations additions.
Commercial Litigations Additions
Commercial litigation, Additions
Level 2 of fair value hierarchy [member]
Level 2 [member]
Disclosure of information about consolidated and non-consolidated structured entities.
Disclosure Of Information About Consolidated And Non-consolidated Structured Entities [Line Items]
Disclosure of Information about Consolidated and Non-consolidated Structured Entities [Line Items]
Earnings per share [text block]
Earnings per share
Executive employees.
Executive Employees [Member]
Employee litigation and severance, Beginning balance
Provisions For Employee Litigation and Severance
Provisions for employee litigation and severance.
Employee litigation and severance, Ending balance
Other non-current assets
Other non-current assets
Other non-current assets
BPI Agreement [Member]
B P I Agreement [member]
B P I Agreement.
Decrease In Interest Income Earned On Cash Cash Equivalents And Financial Assets
Decrease in interest income earned on cash, cash equivalents and financial assets.
Decrease in interest income earned on cash, cash equivalents and financial assets
Addition for non current provision.
Addition For Non Current Provision
Non current provisions additions
Line items represent concepts included in a table. These concepts are used to disclose the amount of expenses aggregated according to their nature (for example, depreciation, purchases of materials, transport costs, employee benefits and advertising costs), and not reallocated among functions within the entity.
Expense by Nature [Line Items]
Expense by nature [line Items]
Collaboration agreement.
Collaboration Agreement [axis]
Major components of tax expense (income) [abstract]
Deferred tax assets
Deferred tax assets
Deferred tax assets
Proceeds from sales of investments other than investments accounted for using equity method
Proceeds from the sale of current financial assets
Categories of financial liabilities [domain]
Disclosure of revenue [line items]
Disclosure of revenue [line items]
Disclosure of revenue [line items]
Types of warrants [Domain]
Types of warrants [Domain]
Disclosure of transactions between related parties [table]
The amount represents the research tax credit income for the period. The research tax credit is a French tax credit calculated based on our claimed amount of eligible research and development expenses in France. It can be offset against French corporate income tax due and the portion in excess (if any) may be refunded at the end of a three fiscal-year period.
Research Tax Credit Amount
Research tax credit subsidy
Weighted average exercise price of share options change in conversion ratios in sharebased payment arrangement 2019.
Weighted Average Exercise Price Of Share Options Change In Conversion Ratios In Sharebased Payment Arrangement 2019
Weighted average exercise price per share, Additional shares due to change in conversion ratios
Fair value per options.
Fair Value Per Options
Fair value per options (in euros per share)
Fair value per options
Bank deposits, not classified as cash equivalents.
Bank Deposits Not Classified As Cash Equivalents
Bank deposits
Increase (decrease) in foreign exchange gains.
Increase (decrease) in foreign exchange gains
Disclosure of impairment loss and reversal of impairment loss [line items]
Measurement [axis]
Disclosure of Activities of Company Explanatory
Disclosure of Activities of Company Explanatory
The Company
Financial assets
Financial assets at end of period
Financial assets at beginning of period
Total financial assets
Book value on the statement of financial position
Disclosure of quantitative information about right-of-use assets [text block]
Right-of-use assets
Disclosure of classes of share capital [abstract]
Issued capital [member]
Share Capital Issued Capital [member]
Later than one year and not later than five years [member]
One to Five Years [member]
State Guaranteed Loan.
State Guaranteed Loan [Member]
State Guaranteed Loan [Member]
Weighted average remaining contractual life of outstanding share options
Remaining Average Useful Life
Later than three years and not later than five years [member]
3-5 years [member]
Other current liabilities
Other current liabilities
Total other current liabilities
Agreement two.
Agreement Two [Domain]
Disclosure of offsetting of financial liabilities [table]
Disclosure of offsetting of financial liabilities [table]
The increase (decrease) in liabilities arising from financing activities resulting from financing cash flows, excluding interest payments.
Increase (Decrease) Through Financing Cash Flows (Excluding Interest Payments), Liabilities Arising from Financing Activities
Debt repayments financial liabilities and lease debts
Warrants Valuation.
Warrants Valuation [Abstract]
Contractual repayment schedule [member]
Contractual repayment schedule.
Contractual Repayment Schedule [Member]
Other comprehensive income that will be reclassified to profit or loss net of tax from continuing operations.
Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net Of Tax From Continuing Operations
Other comprehensive income (loss) that will be reclassified subsequently to income or loss from continuing operations
The increase in contract liability balances resulting from consideration received from customers.
Increase Due to Consideration Received from Customers, Contract Liabilities
Additional consideration from customers
Personnel expenses
Compensation expense
Total employee benefits expense
Share-based compensation expense
Employee benefits expense
Personnel expenses
The increase in liabilities arising from financing activities resulting from the non-cash capitalization of interest expense.
Increase Through Capitalization of Interest Expense (Non-Cash), Liabilities Arising from Financing Activities
Interest expense financial liabilities and lease debts
Contractual life options.
Contractual Life Options
Contractual life of options
Lease potential obligations.
Lease Potential Obligations
Lease potential commitment
Schedule of Share Capital Information
Disclosure of Detailed Information of Share Capital Explanatory [text block]
Disclosure of Detailed Information of Share Capital Explanatory.
Adjustments to reconcile profit (loss) [abstract]
Adjustment to reconcile net loss to cash used in operating activities
Expected amount of discounting adjustment.
Expected Amount of Discounting Adjustment
Expected amount of discounting adjustment
Accrued and unpaid interest accrued.
Accrued And Unpaid Interest Accrued [Member]
Disclosure Of Number And Weighted Average Exercise Prices Of Share Options AND Awards [Abstract]
Disclosure Of Number And Weighted Average Exercise Prices Of Share Options AND Awards [Abstract]
Levels of fair value hierarchy [domain]
Net financial gain (loss) improved
Increasr Decrease In Net Financial Gain Loss
Increasr decrease in net financial gain loss.
The portion of the research tax credit receivable which is expected to be refunded within twelve months after the reporting period.
Reserach tax credit receivable current
Research tax credit